• KCNJ9 3765 Druggable Genome

    Alternate Names:

    3765
    POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY J MEMBER 9
    KCNJ9
    GIRK3
    KIR3.3
    600932
    6270
    ENSG00000162728
    OTTHUMG00000024072
    G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 3 (GIRK3) (POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 9) (INWARDLY RECTIFIER K(+) CHANNEL KIR3.3). [SOURCE:UNIPROT/SWISSPROT;ACC:Q92806]
    Q92806
    436
    K<sub>ir</sub>3.3
    BE0005190
    KCNJ9_HUMAN
    NP_004974
    NM_004983
    potassium inwardly-rectifying channel, subfamily J, member 9

    Gene Info:

    Human Readable Name DRUGGABLE GENOME
    Target Class Transporter
    Target Subclass TC:1.A.2.1
    Initial Gene Query Kir3.3
    Counted Citations from 1950-2000 57
    Gene Category Ion Channel
    GuideToPharmacology Gene Category Name Inwardly rectifying potassium channels
    GuideToPharmacology Gene Category ID 74
    GuideToPharmacology Gene Type vgic
    Gene Biotype PROTEIN_CODING"
    (5 More Sources)

    Publications:

  • Interaction Types:
    activator

    Interaction Info:
    Specific Action of the Ligand None
    Endogenous Drug? True
    Direct Interaction? False

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:
    Trial Name flupirtine,Effirma
    Novel drug target Novel Target

    Publications: